Elizabeth Thomas

Liz Thomas qualified as an analytical chemist while working at Glasgow University and has been in the CRO and pharmaceutical industries for over 25 years. In 2011, she joined ICON as vice president and general manager of the European bioanalytical business with a major role in the harmonization and development of the bioanalytical business globally. “Before ICON, I worked at AstraZeneca, where I was responsible for providing scientific, regulatory and strategic leadership globally and locally.” Liz has represented both ICON and AstraZeneca on the European Bioanalysis Forum (EBF) and is a member of a Global Bioanalytical Consortium (GBC) harmonization team.